tiprankstipranks

Martin Sutter Insider Profile

11 Followers
Martin Sutter, Director at Abiomed, holds 13.08M shares in Bioventus (Ticker: BVS), holds 0.00 shares in Abiomed (Ticker: ABMD), holds 1.30M shares in Echo Therapeutics (Ticker: ECTE).
tipranks
Martin Sutter

Martin Sutter
Abiomed (ABMD)
Director

Ranked #12,916 out of 99,335 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+39.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$151M
100.00%
A breakdown of Martin Sutter's holdings

Insider Roles

Bioventus
(BVS)
Director
Roles that Martin Sutter holds in companies

Most Profitable Insider Trade

Stock:
Abiomed
(ABMD)
Rating:Informative Buy
Date:Jun 02, 2015 - Jun 02, 2016
Return:+70.70%
The most profitable trade made by Martin Sutter

Martin Sutter's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ABMD
Abiomed
Dec 27, 2022
Uninformative Sell
$0.00
Bioventus
Jun 11, 2024
Director
Uninformative Buy
192.43K
$150.55M
ECTE
Echo Therapeutics
$38.94K
CTIC
CTI BioPharma
LJPC
La Jolla Pharma
Aug 07, 2009
Informative Sell
403.28K
$0.00
List of latest transactions for each holding click on a transaction to see Martin Sutter's performance on stock

Martin Sutter insider profile FAQ

What is the percentage of profitable transactions made by Martin Sutter?
The percentage of profitable transactions made by Martin Sutter is 75%.
    What is the average return per transaction made by Martin Sutter?
    The average return per transaction made by Martin Sutter is 39.10%.
      What stocks does Martin Sutter hold?
      Martin Sutter holds: ABMD, BVS, ECTE, CTIC, LJPC stocks.
        What was Martin Sutter’s latest transaction?
        Martin Sutter latest transaction was an Uninformative Buy of $192.43K.
          What was Martin Sutter's most profitable transaction?
          Martin Sutter’s most profitable transaction was an Informative Buy of ABMD stock on June 2, 2015. The return on the trade was 70.70%.
            What is Martin Sutter's role in Abiomed?
            Martin Sutter's role in Abiomed is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.